News

India lifts controls on drug prices

BMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6958.830 (Published 01 October 1994) Cite this as: BMJ 1994;309:830
  1. G Nandan

    India will lift price controls on half of its drugs and allow foreign pharmaceutical firms to enter the country more easily under a new drug policy announced last week. The 1994 drug policy, part of India's three year programme of economic liberalisation, reduces the number of drugs under price control from 142 to 73.

    The government has also decided to give “automatic approval” to foreign technology agreements on all products except those produced by recombinant DNA technology.

    The policy has evoked a largely positive reaction from sections of the pharmaceutical industry that regard it as a major step towards deregulating …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe